A self-guided web app helps epileptic kids to have a sleep 16 mins earlier than normal. Discover why human support is crucial ...

Internal circadian rhythms influence immune biomarkers and may affect bacterial infection risk, beyond genetics or environment.

Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

Alkermes wins FDA Breakthrough Therapy status for alixorexton in NT1 after Vibrance-1 data shows improvement in wakefulness.

Secil Aydinoz, MD, says helping people was his motivation in choosing medicine as a career.

Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1), ...

Most people sometimes have a night or two when they just can’t fall asleep, but if it becomes a recurring problem and it impacts your daytime routine, there are many sleep aids to consider. Sarah ...